Skip to Content
COVID-19 Resources
Cancer Imaging Program (CIP)
Contact CIP
Show menu
Search this site
Last Updated: 10/28/16

Sixth National Forum on Biomedical Imaging in Oncology

April 7-8, 2005

Hyatt Regency Bethesda
Bethesda, Maryland

The National Forum on Biomedical Imaging in Oncology (NFBIO) was created to facilitate partnerships with the imaging industry and government agencies to address new biomedical opportunities and challenges in oncology. It focuses on the scientific and technological issues in emerging imaging technologies and the regulatory, coverage, and reimbursement issues for more developed and established technologies. The NFBIO fosters the advancement of more accessible and accurate imaging technology and movement of interventions into the clinic. This year’s program on quantitative oncologic imaging is of major interest and importance to clinicians, clinical investigators, imaging equipment manufacturers, developers of new cancer chemotherapeutic agents, image processing scientists, regulatory personnel, and CROs.

Presentations from the Sixth National Forum on Biomedical Imaging in Oncology

Presented by:
The National Cancer Institute (NCI)
Food and Drug Administration (FDA)
Centers for Medicare and Medicaid Services (CMS)
National Electrical Manufacturers Association (NEMA)

The focus of the Sixth National Forum on Biomedical Imaging in Oncology was on Quantitative Oncologic Imaging. The meeting opened with updates from NEMA, the U.S. Food and Drug Administration (FDA), and Center for Medicare and Medicaid Services (CMS), summarizing progress made on issues raised at the 2004 Forum. Also in the opening session, the NCI updated on the review of the clinical trials process and current imaging activities.

The afternoon session on the first day included a keynote presentation on the critical need for quantitative oncologic imaging, then proceeded with presentations on tumor response criteria, imaging in clinical trials of cancer therapeutic agents, biological issues in quantitative oncologic imaging, high sensitivity and specificity agents, and detection devices.

Panel discussions were held following the morning and afternoon sessions.

Meeting Program and Presentations:

April 7

Time Topic Speaker
8:30 am Welcome and Opening Remarks Daniel Sullivan, MD
8:45 am Welcome from the National Electrical Manufacturers Association (NEMA) Thomas McCausland
9:00 am Welcome from NCI/DCTD and Update on NCI Review of Clinical Trials Process James Doroshow, Ph.D.
9:15 am Update on NCI Imaging Activities Daniel Sullivan, MD
9:40 am Update from FDA/Center for Devices and Radiological Health Daniel Schultz, MD
10:30 am Update from FDA/Center for Drug Evaluation and Research Janet Woodcock, MD
10:50 am Update from Center for Medicare and Medicaid Services (CMS) Stephen Phurrough, MD, MPA
11:10 am Panel Discussion Sullivan, McCausland, Doroshow, Schultz, Woodcock, Phurrough, George Mills
1:00 pm Keynote Address: The Need for Quantitative Imaging in Oncology Richard Schilsky, MD
1:45 pm Tumor Response Criteria: Anatomic (RECIST) & Functional Approaches Larry Schwartz, MD
2:15 pm Imaging Trials of Cancer Therapeutic Agents: Pharmaceutical Perspective Susan Galbraith, MD, PhD
3:15 pm Biological Issues in Oncology Imaging Roy Herbst, MD, PhD
3:45 pm Development of High Sensitivity & Specificity Imaging Agents: Challenges & Opportunities Michael Tweedle, PhD
4:15 pm Detection Device/Acquisition Issues Kyle Myers, PhD
4:45 pm Panel Discussion Schilsky, Schwartz, Galbraith, Herbst, Tweedle, Myers, Paula Jacobs, PhD

April 8

Time Topic Speaker
8:00 am The Forefront in Imaging Processing: Anatomic/Physiologic Approaches Richard Robb, PhD
8:35 am The Forefront in Imaging Processing: PET/Molecular Approaches Joel Karp, PhD
9:10 am Building Large Publicly-Available Image Archives Larry Clarke, PhD
10:00 am Standardizing Image Acquisition Jeff Evelhoch, PhD
10:30 am The Data Explosion: How Can We Achieve Inter-operability?
Moderator: Larry Clarke, PhD
James Williams, PhD
F David Rollo, MD, PhD
Wesley Turner, PhD
11:30 am Panel Discussion Robb, Karp, Clarke, Evelhoch, Williams, Rollo, Turner

Note: PDF documents can be viewed by anyone with Adobe Acrobat Reader. Download the free Adobe Acrobat Reader